Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Refereed |
Title | Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis? |
Journal | Formal name:Targeted oncology ISSN code:1776260X/17762596 |
Domestic / Foregin | Foregin |
Volume, Number, Page | 18(2),pp.221-233 |
Papers・Author | Margherita Rimini, Mara Persano, Tada Toshifumi, Suda Goki, Shimose Shigeo, Kudo Masatoshi, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Francesca Salani, Sara Lonardi, Fabio Piscaglia, Kumada Takashi, Sakamoto Naoya, Iwamoto Hideki, Aoki Tomoko, Hong Jae Chon, Vera Himmelsbach, Marta Schirripa, Margarida Montes, Caterina Vivaldi, Caterina Soldà, Hiraoka Atsushi, Iijima Hiroko…Andrea Casadei-Gardini |
Publication date | 2023/03 |